regorafenib in refractory biliary tract cancer
Published 4 years ago • 61 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
7:35
use of regorafenib in refractory mcrc
-
4:47
regorafenib nivolumab in mmr proficient advanced crc
-
0:45
zev wainberg, md, considers regorafenib in locally advanced biliary tract cancer
-
1:49
regorafenib and pembrolizumab in pre-treated hepatocellular carcinoma
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
1:42
randomized phase ii study of regorafenib in refractory aogc
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
2:52
metastatic colorectal cancer: trifluridine/tiripacil or regorafenib?
-
1:25
treating crc with regorafenib in latin america
-
8:44
debate: optimal salvage therapy for refractory colon cancer? - tas102 or regorafenib
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
5:31
practical advice for using regorafenib
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
4:14
the use of regorafenib in clinical practice
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
9:34
regorafenib in colorectal cancer
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist